Breast Carcinoma by Gene Expression Profile

Breast Carcinoma by Gene Expression Profile — Trials · CancerIndex

Clinical trials

Registered studies

1,299 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 537
Recruiting: 296
Ph III recruiting: 38
Growth YoY: +1.9%
Industry share: 28%
Top sponsor: Fudan University
Termination share: 46%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (217)

clinicaltrialsPublishedShowing 1–50 of 140 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05007106	MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)	completed	Phase 2	611	Merck Sharp & Dohme LLCINDUSTRY	15	Sep 28, 2026	clinicaltrials
NCT03644186	To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)(TOUCH)	completed	Phase 2	147	ETOP IBCSG Partners FoundationNETWORK	4	Aug 26, 2026